Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Fakhouri · SciRah

Researcher profile · Semantic Scholar

W. Fakhouri

Share profile

W. Fakhouri — researcher profile on SciRah

h-index: 4
Works: 15
Citations: 28

Most-cited papers

ize and Treatment Outcomes of HR+, HER2- Early Breast Cancer Population With High Risk of recurrence: A Real-World Cohort Study With Danish Breast Cancer Cooperative Group Registry Data
H. Loponen, Juha Mehtälä, Laila Mehkri, Astrid Torstensson +3 more
2025Journal of health economics and outcomes research5 citations Open access
Semantic Scholar
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
P. Taylor, W. Fakhouri, Samuel Ogwu, E. Haladyj +5 more
2024Rheumatology and Therapy5 citations Open access
Semantic Scholar
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
I. Blancas, Jessica Grosjean, R. Pedersini, Carlotta Buzzoni +10 more
2024Future Oncology5 citations Open access
Semantic Scholar
Patient Profile and Outcomes Among Patients with Rheumatoid Arthritis Treated with Baricitinib Versus Other Therapies in Spain: The RA-BE-REAL Study
M. García-Vivar, Á. Prior-Español, W. Fakhouri, S. Díaz-Cerezo +5 more
2025Rheumatology and Therapy4 citations Open access
Semantic Scholar
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study
L. E. Kristensen, K. Ng, Marcus E. Ngantcha, J. Morel +13 more
2024RMD Open4 citations Open access
Semantic Scholar
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
W. Fakhouri, Xiao-Fei Wang, I. de la Torre, C. Nicolay
2020Journal of health economics and outcomes research3 citations Open access
Semantic Scholar
Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study
J. King, W. Fakhouri, R. Jarvis, Waleed Badreldin +3 more
2025BMC Cancer1 citations Open access
Semantic Scholar
Journal of Health Economics and Outcomes Research
H. Loponen, Juha Mehtälä, Laila Mehkri, Astrid Torstensson +3 more
1 citations
Semantic Scholar
AD-REAL: A Prospective, Multinational, Observational Cohort Study of Clinical Effectiveness and Treatment Discontinuation of Oral Systemics for Moderate-to-Severe Atopic Dermatitis
M. Augustin, A. Pinter, Silvia Sabatino, Louis P. Sanden +7 more
2026Dermatologic Therapy0 citations Open access
Semantic Scholar
Treatment and outcomes of patients with HR+/HER2- early breast cancer in a real-world setting in Germany.
K. Däßler, Volker Petersen, Mark-Oliver Zahn, W. Fakhouri +7 more
2026Cancer Treatment and Research Communications0 citations Open access
Semantic Scholar
E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data
N. Gullick, J. Morel, E. Lubrano, A. Kronbergs +7 more
2025Rheumatology0 citations Open access
Semantic Scholar
THE IMPACT OF DISEASE ACTIVITY AND PAIN LEVEL ON PRODUCTIVITY IN RHEUMATOID ARTHRITIS (RA) PATIENTS
J. Galloway, J. Capron, F. De Leonardis, W. Fakhouri +10 more
20230 citations
Semantic Scholar
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
C. J. van de Laar, M. O. Voshaar, W. Fakhouri, L. Zaremba-Pechmann +3 more
20200 citations
Semantic Scholar
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
C. J. van de Laar, M. O. Voshaar, W. Fakhouri, L. Zaremba-Pechmann +3 more
20200 citations
Semantic Scholar
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
C. J. van de Laar, M. O. Voshaar, W. Fakhouri, L. Zaremba-Pechmann +3 more
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. de la Torre×7
Invite
I. de la Torre — researcher profile on SciRah
Anna Emde×4
Invite
Anna Emde — researcher profile on SciRah
C. J. van de Laar×3
Invite
C. J. van de Laar — researcher profile on SciRah
M. O. Voshaar×3
Invite
M. O. Voshaar — researcher profile on SciRah

L. Zaremba-Pechmann

×3

Invite

L. Zaremba-Pechmann — researcher profile on SciRah

F. De Leonardis×3

Invite

F. De Leonardis — researcher profile on SciRah

M. A. van de Laar×3

Invite

M. A. van de Laar — researcher profile on SciRah

Invite

H. Loponen — researcher profile on SciRah

Juha Mehtälä×2

Invite

Juha Mehtälä — researcher profile on SciRah

Laila Mehkri×2

Invite

Laila Mehkri — researcher profile on SciRah

Astrid Torstensson×2

Invite

Astrid Torstensson — researcher profile on SciRah

T. Ylisaukko-Oja×2

Invite

T. Ylisaukko-Oja — researcher profile on SciRah